Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Bevacizumab/oxaliplatin

Partial thrombosis of the hepatic portal vein and nodular regenerative hyperplasia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Fluxa C D, et al. Portal vein thrombosis and nodular regenerative hyperplasia associated with the use of bevacizumab and oxaliplatin. Report of one case]. . Revista Medica de Chile 141: 1344-8, No. 10, Oct 2013 [Spanish; summarized from translation] - ChileCrossRefPubMed Fluxa C D, et al. Portal vein thrombosis and nodular regenerative hyperplasia associated with the use of bevacizumab and oxaliplatin. Report of one case]. . Revista Medica de Chile 141: 1344-8, No. 10, Oct 2013 [Spanish; summarized from translation] - ChileCrossRefPubMed
Metadaten
Titel
Bevacizumab/oxaliplatin
Partial thrombosis of the hepatic portal vein and nodular regenerative hyperplasia: case report
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9877-5

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Topiramate

Case report

Ampicillin